National and Kapodistrian University of Athens
Μελέτη των νευρογνωσιακών/νευροψυχολογικών διαταραχών σε νεοδιαγνωσμένους ασθενείς με λοίμωξη από το ιό της επίκτητης ανοσοανεπάρκειας του ανθρώπου σε συνδυασμό με βιολογικές και απεικονιστικές παραμέτρους
Abstract
dc:descriptionHIV-associated neurocognitive disorders (HAND) continue to affect people living with HIV, even in the era of combined antiretroviral therapy (cART). Despite the remarkable advances in the treatment of HIV infection, which has now become a manageable chronic disease with life expectancy approaching that of the general population, the entry of the virus into the central nervous system during the early phase of infection has long-term consequences. The aim of this study was to investigate the prevalence of HAND in newly diagnosed individuals with HIV in Greece, its prospective course following cART initiation, and its association with biological and neuroimaging biomarkers. To diagnose HAND, the commonly accepted Frascati criteria were applied, based on an extensive neuropsychological assessment and the exclusion of other causes of cognitive impairment. In parallel, plasma biomarkers previously linked with HAND were measured, including general inflammatory markers, markers of macrophage activation, and a marker of neuroaxonal degeneration, neurofilament light chain. At both study visits, a comprehensive neuroimaging protocol was performed, including morphometry, diffusion imaging, and resting-state functional MRI.A total of 39 individuals (37 male) with HIV infection were enrolled, with a mean age of 37.7 (±10.7) years. At baseline, HAND was identified in 45.7% of participants, most commonly presenting as asymptomatic neurocognitive impairment. At the 18-month follow-up after cART initiation, this proportion decreased to 32.1% (p = 0.25), with significant improvements observed in processing speed, executive functions, and visuospatial abilities. Among plasma biomarkers, the most significant improvements were recorded in macrophage activation markers, which at follow-up also demonstrated negative correlations with cognitive performance. Specifically, MCP1 and MIP1b were inversely correlated with visuospatial abilities (p = 0.002 and 0.003, respectively); CD14 and CD163 with motor skills (p = 0.011 and 0.006, respectively); and MIP1b and CD163 with processing speed (p = 0.014 and 0.031, respectively). With regard to neuroimaging, our analyses revealed significant differences both between groups (with vs. without HAND) and between the two study visits (before and 18 months after cART initiation). Volumetric analysis of the entire cohort demonstrated a reduction in left putamen volume at 18 months, while the HAND group exhibited lower cortical thickness and increased gyrification in bilateral frontal regions. Diffusion imaging revealed significant longitudinal changes, mainly in two right hemisphere tracts—the superior longitudinal fasciculus and the inferior fronto-occipital fasciculus. These changes primarily involved water diffusivity indices rather than axonal integrity, suggesting reductions in edema and inflammation. Importantly, greater decreases in diffusivity in the superior longitudinal fasciculus were associated with greater improvements in attention and working memory, whereas decreases in the inferior fronto-occipital fasciculus were associated with gains in learning and memory. We further confirmed that cART can reverse the effects of HIV infection on brain functional networks, which are typically characterized by decreased frontal connectivity and increased posterior connectivity. Among participants with HAND, cART initiation was followed by enhanced connectivity in the dorsal attention network and increased coupling between the salience network and executive regions of the brain. At the same time, a reduction in coupling between the frontoparietal network and the default mode network was observed, reflecting restoration of functional segregation of central control networks, favoring improved cognitive performance. In summary, this doctoral thesis documents, in newly diagnosed individuals with HIV initiating cART, a consistent pattern of neurobiological “normalization” manifested as stability and/or improvement in selected cognitive domains, reductions in immune activation markers, and longitudinal neuroimaging changes consistent with decreased white matter inflammation, reorganization of functional connectivity with strengthening of attention and executive hubs, and more effective functional segregation of control networks. Overall, our findings underscore that early initiation of cART can support sustained cognitive health in people living with HIV by promoting both immunological and neurobiological recovery.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Moschopoulos, Charalampos
- Μοσχόπουλος, Χαράλαμπος
Subjects
dc:subject × 16- HIV-σχετιζόμενες νευρογνωσιακές διαταραχές
- Αντιρετροϊκή αγωγή
- HIV λοίμωξη
- Νευροαπεικόνιση
- Βιοδείκτες
- HIV-associated neurocognitive disorders (HAND)
- Antiretroviral treatment
- NeuroHIV
- Neuroimaging
- Biomarkers
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική ιατρική, άλλοι τομείς
- Clinical Medicine
- Medical and Health Sciences
- Clinical medicine, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59960